Do Orally Administered Immunoglobulin-Based Agents Represent the Future of IBD Therapeutics?
- PMID: 26182902
- DOI: 10.1007/s10620-015-3802-x
Do Orally Administered Immunoglobulin-Based Agents Represent the Future of IBD Therapeutics?
Comment on
-
Attenuation of Colitis by Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Defined Microbiota Mouse Model.Dig Dis Sci. 2015 Nov;60(11):3293-303. doi: 10.1007/s10620-015-3726-5. Epub 2015 May 31. Dig Dis Sci. 2015. PMID: 26026602 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources